SPP1 and multiple sclerosis: Other proteins including glial marker chitinase-3-like-1 [10], and inflammatory cytokine osteopontin [11], have also been identified as potential candidates for predicting multiple sclerosis outcomes, and may offer complementary information to neurofilament light.